PIEZO1 and cardiac hypertrophy: Studies have shown that the use of Piezo1 inhibitors can significantly alleviate pressure overload-induced myocardial hypertrophy, reduce heart weight, and improve both ventricular systolic function and diastolic compliance (Yuan et al., 2023; Merten et al., 2024).